Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2011
02/23/2011CN101979405A Immune dominant HLA-A3 super-type restrictive CTL epitope of hepatitis B virus core antigen and identification method and application thereof
02/23/2011CN101595849B Flounder tetraplont fry batch induction method
02/23/2011CN101333564B Method for extracting and purifying target nucleic acid and use thereof
02/22/2011US7895024 Sequence pattern descriptors for transmembrane structural details
02/22/2011US7894997 Multidimensional morphological reconstruction of genome expression activity
02/22/2011US7894992 Diagnosis and classification of multiple myeloma
02/22/2011US7894057 Methods of analyzing samples using broadband laser light
02/22/2011US7893325 Brassica plant resistant to the fungus Leptosphaeria maculans (blackleg)
02/22/2011US7893322 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants
02/22/2011US7893253 Aminating reducing sugar; mass spectrometry
02/22/2011US7893250 Demethylated and/or oxidized membrane DNA
02/22/2011US7893247 siRNA targeting spleen tyrosine kinase
02/22/2011US7893246 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer
02/22/2011US7893245 Interfering RNA molecules
02/22/2011US7893242 Oligonucleotide compositions and their use to induce apoptosis
02/22/2011US7893241 Articles of manufacture for detection of herpes simplex virus
02/22/2011US7893233 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
02/22/2011US7893224 Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
02/22/2011US7893217 Isolated human antibodies that bind epitopes on RG1
02/22/2011US7893209 Slo2, novel potassium channel proteins from human brain
02/22/2011US7893206 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof
02/22/2011US7893204 Attractin/mahogany-like polypeptides
02/22/2011US7893054 Materials and methods relating to protein aggregation in neurodegenerative disease
02/22/2011US7893008 Oligonucleotides, arrays thereof for detecting microorganisms, and an apparatus, a method and a kit for detecting microorganisms
02/22/2011US7893007 Directed evolution of novel binding proteins
02/22/2011US7892856 Flow-controlled magnetic particle manipulation
02/22/2011US7892854 Bioassay for qualitative and/or quantitative molecular interaction analysis between an analyte and binding agent; competitive binding assays
02/22/2011US7892842 Procedure for the determination of the activity of the protease which activates factor VII from protein solutions
02/22/2011US7892834 Cellular signal-responsive gene transcriptional regulation system
02/22/2011US7892828 Method of identifying a MHC class I restricted T cell response
02/22/2011US7892819 Mesoscale polynucleotide amplification devices
02/22/2011US7892818 Method and kit for the determination of cellular activation profiles
02/22/2011US7892812 Chrysosporium cellulase and methods of use
02/22/2011US7892803 Gene and uses therefor to modify pasture qualities of crops
02/22/2011US7892801 Process for enhancing the activity of glucose oxidase
02/22/2011US7892799 Method for in vivo, ex vivo and in vitro repair and regeneration of cartilage
02/22/2011US7892797 Single enzyme system for fast, ultra long PCR
02/22/2011US7892796 Solid support assay systems and methods utilizing non-standard bases
02/22/2011US7892795 Methods and compositions for detecting BK virus
02/22/2011US7892794 Using apparatus which generates alternating electric pulses to isolate preferential bioparticles from gas; utilizing cyclic replication to amplify recovered biopolymers
02/22/2011US7892793 Allele-specific RNA interference
02/22/2011US7892785 In vito translation o proteins; obtain nucleotide sequences, incubate with reaction mixtures, translate, recover proteins
02/22/2011US7892783 Culture medium for detecting and identifying Vibrio bacteria
02/22/2011US7892782 Screening process for antibacterial agents
02/22/2011US7892781 Detecting a target using a composite probe comprising a directing agent, a metal nanoparticle and an enzyme
02/22/2011US7892780 Method for screening antioxidant using mutant bacteria and chlorophyllide, and antioxidant screened by the method
02/22/2011US7892779 Method of determining chymase activity with secretory leukocyte protease inhibitor
02/22/2011US7892778 Generating transgenic worms comprising construct which expresses gamma -secretase; identifying modulators for treatment and prevention of alzhemier's disease
02/22/2011US7892777 Methods for measuring whether a treatment affects RPTP-κ activity
02/22/2011US7892776 Screening assay to identify modulators of protein kinase A
02/22/2011US7892775 Fluorescence assay for kinase activity
02/22/2011US7892773 Expression vector comprising nucleotide sequences coding homeobox transcriptional regulator gene for identifying modulators for treatment and prevention of cell proliferative disorders of urogenital system
02/22/2011US7892765 Methods of screening modulators of hetero-oligomeric sweet taste receptors
02/22/2011US7892759 Enhanced sensitivity of a cantilever sensor via specific bindings
02/22/2011US7892754 Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof
02/22/2011US7892748 Reagent for detecting an analyte
02/22/2011US7892747 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
02/22/2011US7892746 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
02/22/2011US7892745 Methods and compositions for diagnosing and monitoring transplant rejection
02/22/2011US7892744 Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disorders
02/22/2011US7892743 Subtractive single label comparative hybridization
02/22/2011US7892742 PCR screening method
02/22/2011US7892741 Methods, kits and compositions pertaining to linear beacons
02/22/2011US7892740 Prognosis and therapy predictive markers and methods of use
02/22/2011US7892739 Systems, compositions and methods for nucleic acid detection
02/22/2011US7892738 Pot1 alternative splicing variants
02/22/2011US7892737 Compositions, kits and methods pertaining to stability modulation of PNA oligomer/nucleic acid complexes
02/22/2011US7892736 Selecting a domestic animal for having desired genotypic properties bytesting the animal for the presence of a parentally imprinted quantitative trait locus; particularly selecting properties related to muscle mass, fat deposition, sow prolificacy, and/or sow longevity in pigs
02/22/2011US7892735 Genetic markers of schizophrenia spectrum disorders in the sulfotransferase 4a (sult4a) gene
02/22/2011US7892734 Aptamer based colorimetric sensor systems
02/22/2011US7892733 Response element regions
02/22/2011US7892732 Method of performing PCR amplification on a microarray
02/22/2011US7892731 System and method for inhibiting the decryption of a nucleic acid probe sequence used for the detection of a specific nucleic acid
02/22/2011US7892730 Nucleotide sequences coding polypeptide for use in the treatment of and detection of cancer
02/22/2011US7892729 Universal and differential serologic assay for swine influenza virus
02/22/2011US7892728 Transporter protein in mammal and utilization of the same
02/22/2011US7892727 Chemokine-binding protein and methods of use
02/22/2011US7892551 Antibody kit for enumeration of CD4+ lymphocytes
02/22/2011US7892539 Modulation of an innate immune response by altering TRIAL-R signaling
02/22/2011US7892484 Exposure to semiconductor; neutralization
02/22/2011CA2683861C Process challenge device for assessing the effective performance of a biocontamination deactivation process
02/22/2011CA2610929C Methods and kits for sense rna synthesis
02/22/2011CA2495944C Enzyme catalyzed organosilicon carbohydrates
02/22/2011CA2476296C Amino-derivatives as inhibitors of histone deacetylase
02/22/2011CA2455932C Assay electrodes having immobilized lipid/protein layers, methods of making the same and methods of using the same for luminescence test measurements
02/22/2011CA2435503C Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
02/22/2011CA2423833C Viruses targeted to hypoxic cells and tissues
02/22/2011CA2410193C Neuronal serine-threonine protein kinase
02/22/2011CA2356255C Use of a xylanase in the preparation of dough
02/22/2011CA2335730C Method for marking a ribonucleic acid and resulting marked rna fragments
02/22/2011CA2266334C Method for determining ion channel activity of a substance
02/22/2011CA2253875C Early detection of lysosomal storage disorders
02/22/2011CA2251793C Multiplex amplification of short tandem repeat loci
02/22/2011CA2143491C A novel peptide related to human programmed cell death and dna encoding it
02/17/2011WO2011020089A2 Target genes for cancer therapy
02/17/2011WO2011020075A2 Amelogenin snp on chromosome x
02/17/2011WO2011020049A1 Biological markers for monitoring patient response to vegf antagonists
02/17/2011WO2011020012A1 Lack of expression of tnfa and type 1 receptor for tnfa protects cancer cells from tnfa-induced programmed cell death (cell apoptosis)
02/17/2011WO2011020011A2 Droplet actuator and droplet-based techniques
02/17/2011WO2011019993A2 METHODS, COMPOSITIONS, AND KITS FOR GENERATING rRNA-DEPLETED SAMPLES OR ISOLATING rRNA FROM SAMPLES